Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
Z
Zenith Healthcare Ltd
Score 68/100• Decent
Zenith Healthcare Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health42/100
Valuation 60/100 · PB 2.8612
Technical Avoid
1M -6.667% 6M -11.857% 1Y -32.993%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#31
View details ➜
W
Windlas Biotech Ltd
Score 68/100• Decent
Windlas Biotech Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health84/100
Valuation 40/100 · PB 3.9402
Technical Avoid
1M 4.089% 6M -2.44% 1Y -15.278%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#32
View details ➜
V
Vilin Bio Med Ltd
Score 68/100• Decent
Vilin Bio Med Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
Company’s Health52/100
Valuation 80/100 · PB 1.6001
Technical Avoid
1M 6.869% 6M -5.536% 1Y 25.952%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#33
View details ➜
V
Venmax Drugs and Pharmaceuticals Ltd
Score 68/100• Decent
Venmax Drugs and Pharmaceuticals Ltd shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health72/100
Valuation 40/100 · PB 4.6311
Technical Avoid
1M 35.274% 6M 5.581% 1Y 325.532%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#34
View details ➜
T
Tejnaksh Healthcare Ltd
Score 68/100• Decent
Tejnaksh Healthcare Ltd shows potential in the healthcare sector, but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health74/100
Valuation 80/100 · PB 1.3432
Technical Avoid
1M -4.611% 6M -18.385% 1Y -30.096%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#35
View details ➜
S
Suraksha Diagnostic Ltd
Score 68/100• Decent
Suraksha Diagnostic Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health79/100
Valuation 20/100 · PB 7.8766
Technical Avoid
1M 8.277% 6M 6.48% 1Y -23.799%
Confidence100%
Low leverage (D/E)No promoter pledge
#36
View details ➜
S
Strides Pharma Science Ltd
Score 68/100• Decent
Strides Pharma Science Ltd shows potential but faces challenges in growth consistency and market competition.
Company’s Health61/100
Valuation 40/100 · PB 3.331
Technical Watch
1M 3.951% 6M 47.255% 1Y 37.287%
Confidence100%
Healthy profit marginsDecent revenue growth
Promoter pledge present
#37
View details ➜
S
Shilpa Medicare Ltd
Score 68/100• Decent
Shilpa Medicare Ltd shows potential for growth, but faces challenges in profitability and execution risks.
Company’s Health46/100
Valuation 60/100 · PB 2.9196
Technical Avoid
1M -5.325% 6M 11.936% 1Y -16.401%
Confidence100%
Low leverage (D/E)Decent revenue growth
Weak ROEPromoter pledge present
#38
View details ➜
S
SeQuent Scientific Ltd
Score 68/100• Decent
SeQuent Scientific Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health54/100
Valuation 20/100 · PB 7.0022
Technical Momentum
1M 14.127% 6M 49.857% 1Y 17.698%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#39
View details ➜
S
Senores Pharmaceuticals Ltd
Score 68/100• Decent
Senores Pharmaceuticals Ltd shows decent potential for growth and profitability, but caution is advised due to valuation concerns and execution risks.
Company’s Health80/100
Valuation 40/100 · PB 4.3727
Technical Momentum
1M 13.114% 6M 52.276% 1Y 38.444%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#40
View details ➜
S
Sattva Sukun Lifecare Ltd
Score 68/100• Decent
Sattva Sukun Lifecare Ltd shows potential but faces significant challenges in growth and profitability metrics.
Company’s Health77/100
Valuation 80/100 · PB 1.2808
Technical Avoid
1M — 6M -25.544% 1Y -20.165%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#41
View details ➜
S
Sakar Healthcare Ltd
Score 68/100• Decent
Sakar Healthcare Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics.
Company’s Health79/100
Valuation 60/100 · PB 2.8151
Technical Avoid
1M 0.939% 6M 30.988% 1Y 17.083%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#42
View details ➜
R
RPG Life Sciences Ltd
Score 68/100• Decent
RPG Life Sciences Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health100/100
Valuation 20/100 · PB 7.494
Technical Watch
1M 7.838% 6M 15.03% 1Y -4.158%
Confidence100%
Low leverage (D/E)No promoter pledge
#43
View details ➜
O
Onesource Specialty Pharma Ltd
Score 68/100• Decent
Onesource Specialty Pharma Ltd shows potential in a growing sector, but faces challenges in execution and profitability. Caution is advised due to valuation concerns and market risks.
Company’s Health41/100
Valuation 40/100 · PB 3.6109
Technical Avoid
1M 1.41% 6M 16.106% 1Y 8.427%
Confidence100%
Low leverage (D/E)Decent revenue growth
Weak ROEPromoter pledge present
#44
View details ➜
J
JHS Svendgaard Laboratories Ltd
Score 68/100• Decent
JHS Svendgaard Laboratories Ltd shows potential in a growing sector but faces challenges in consistency and valuation. Caution is advised.
Company’s Health42/100
Valuation 100/100 · PB 0.6443
Technical Avoid
1M 22.387% 6M -5.179% 1Y -48.859%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#45
View details ➜
Showing 31 to 45 of 301 (21 Pages)